1-5 of 5
Miguel A. Piris, PhD, MD
Close
Sort by
Journal Articles

MYC and BCL2 mRNA Expression As Determined By NGS Predicts Survival in DLBCL in GCB but Not in ABC Subgroup

Maher Albitar, MD, Xu‐Monette Y Zijun, PhD, Yingjun Wang, Deng Manman, MD, Alexandar Tzankov, Carlo Visco, Govind Bhagat, MD, Karen Dybkær, PhD, Wayne Tam, MD PhD, Eric D. Hsi, MD, Maurilio Ponzoni, MD, Andres JM Ferreri, MD, Michael Boe Møller, Miguel A. Piris, PhD MD, Han van Krieken, MD, Ivan De Dios, BS, Youli Zu, MD PhD, Jane N Winter, MD, Hagop M. Kantarjian, MD, Yong Li, PhD, Ken H. Young
Journal: Blood
Blood (2019) 134 (Supplement_1): 5092.
https://doi.org/10.1182/blood-2019-128492
Published: 2019
Journal Articles

Peripheral T-Cell Lymphomas in Spain: Profiling Clinical, Phenotypic and Genetic Characteristics in Spanish Population

Raul Cordoba, MD PhD, María Socorro Rodriguez-Pinilla, MD, Narvaez Javier, Fina Climent, MD, Joaquin Sanchez, MD, Carlos Perez Seoane, MD, Javier Lopez Jimenez, MD PhD, Monica Garcia Cosio, MD, Dolores Caballero, MD, Óscar Javier Blanco Núñez, MD, Cecilia Carpio, MD, Josep Castellvi, MD, Antonio Martinez Pozo, MD, Ivan Dlouhy, MD, Angeles Bendaña, MD, Carlos Aliste, MD, Ana Julia Gonzalez, MD, María Soledad Fernandez, MD, Sonia González de Villambrosia, MD, Miguel A. Piris, PhD MD, Jose Gomez Codina, MD, Empar Mayordomo, MD, Belén Navarro, MD, Carmen Bellas, MD, Guillermo Rodríguez, MD, Juan José Borrero, MD, Ana Ruiz-Zorrilla, MD, Carmen Montoto, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2938.
https://doi.org/10.1182/blood-2018-99-116562
Published: 2018
Journal Articles

Tipifarnib in Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL) and CXCL12+ Peripheral T-Cell Lymphoma (PTCL): Preliminary Results from an Open-Label, Phase 2 Study

Thomas E. Witzig, MD, Lubomir Sokol, MD PhD, Eric D Jacobsen, MD, Won-Seog Kim, MD PhD, Francine M. Foss, MD, Ranjana H. Advani, MD, Jose Maria Roncero Vidal, MD, Ana Marin Niebla, PhD, Antonia Rodriguez Izquierdo, PhD, Raquel De Ona Navarrete, MD, Fátima de la Cruz Vicente, MD, Dolores Caballero, MD, Rufino Mondejar, PhD, Miguel A. Piris, PhD MD, Robert Curry, BA, MBA, Catherine Scholz, PharmD, Antonio Gualberto, PhD MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2937.
https://doi.org/10.1182/blood-2018-99-116277
Published: 2018
Journal Articles

Identification of Tipifarnib Sensitivity Biomarkers in T-Cell Tumor Cell Lines

Ruth Alonso Alonso, PhD, Rufino Mondejar García, PhD, Jose Pedro Vaqué Díez, PhD, Nuria García Díaz, PhDcandidate, Cristina Pérez Menéndez, PhD, Francis Burrows, PhD, Catherine Scholz, PharmD, Antonio Gualberto, PhD MD, Miguel A. Piris, PhD MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2851.
https://doi.org/10.1182/blood-2018-99-118291
Published: 2018
Journal Articles

The BCL6 Oncogene Drives an Epigenomic Program Linking Stem Cells to the Pathogenesis of Human Diffuse Large B Cell Lymphoma in Mice.

Maria Perez-Caro, PhD, Cesar Cobaleda, PhD, Miguel A. Piris, PhD, MD, Ari M. Melnick, MD, Isidro Snachez-Garcia, PhD, MD
Journal: Blood
Blood (2007) 110 (11): 3372.
https://doi.org/10.1182/blood.V110.11.3372.3372
Published: 2007